Published in Helicobacter on September 01, 2010
Slaying dementia dragons with blood, lungs, and guts. J Am Geriatr Soc (2013) 1.39
Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol (2011) 0.86
Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol (2013) 0.84
Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol (2014) 0.83
An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction? World J Gastroenterol (2014) 0.82
Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection. Can J Gastroenterol (2013) 0.80
Overview of the phytomedicine approaches against Helicobacter pylori. World J Gastroenterol (2014) 0.80
Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study. Gastroenterol Res Pract (2013) 0.80
Detection of Helicobacter pylori in Nasal Polyps. Head Neck Pathol (2016) 0.79
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World J Gastroenterol (2012) 0.79
Can Helicobacter pylori infection influence human reproduction? World J Gastroenterol (2014) 0.77
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
CagA-positive Helicobacter pylori infection and reduced sperm motility, vitality, and normal morphology. Dis Markers (2013) 0.76
No Association between CagA- and VacA-Positive Strains of Helicobacter pylori and Primary Open-Angle Glaucoma: A Case-Control Study. Ophthalmol Eye Dis (2016) 0.75
Unusual Manifestation of Gastric Helicobacter pylori Infection. Case Rep Gastroenterol (2012) 0.75
Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics? Indian J Endocrinol Metab (2015) 0.75
An insight into the relationships between prohepcidin, iron deficiency anemia, and interleukin-6 values in pediatric Helicobacter pylori gastritis. Eur J Pediatr (2015) 0.75
Effect of early and current Helicobacter pylori infection on the risk of anaemia in 6.5-year-old Ethiopian children. BMC Infect Dis (2015) 0.75
Helicobacter pylori in Cholecystectomy Specimens-Morphological and Immunohistochemical Assessment. J Clin Diagn Res (2016) 0.75
Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. J Antibiot (Tokyo) (2016) 0.75
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology (2009) 4.16
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol (2012) 3.88
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet (2007) 3.62
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2010) 3.32
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study. Gut (2006) 2.56
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med (2006) 2.55
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. Hepatology (2014) 2.47
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology (2006) 2.35
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol (2014) 2.21
Use of infliximab in particular clinical settings: management based on current evidence. Am J Gastroenterol (2009) 2.17
Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene. Knee Surg Sports Traumatol Arthrosc (2009) 2.15
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. Dig Liver Dis (2012) 2.11
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet (2003) 2.08
Reflux symptoms in professional opera choristers. Gastroenterology (2007) 2.03
Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol (2002) 2.01
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98
Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol (2005) 1.82
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69
Rating systems for evaluation of the elbow. Br Med Bull (2008) 1.68
Acute cryptogenic liver failure in an untreated coeliac patient: a case report. Eur J Gastroenterol Hepatol (2005) 1.65
Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med (2004) 1.65
Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease. Gastrointest Endosc (2003) 1.64
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Am J Gastroenterol (2006) 1.62
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol (2013) 1.62
The role of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord (2013) 1.62
Increased serum high-density lipoprotein-cholesterol concentration in celiac disease after gluten-free diet treatment correlates with body fat stores. J Clin Gastroenterol (2009) 1.54
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Endometriosis, need for a multidisciplinary clinical setting: the internist's point of view. Intern Emerg Med (2010) 1.53
Acute cholestatic hepatitis associated with celecoxib. Ann Pharmacother (2002) 1.53
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns. Dig Dis Sci (2012) 1.52
Celiac disease associated with autoimmune myocarditis. Circulation (2002) 1.51
Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis. J Clin Gastroenterol (2003) 1.48
Primary renal angiosarcoma: a rare malignancy. A case report and review of the literature. Urol Oncol (2006) 1.47
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. Am J Gastroenterol (2007) 1.42
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest Endosc (2005) 1.41
Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol (2008) 1.38
Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C. Hepatology (2012) 1.35
Oral specific desensitization in food-allergic children. Dig Dis Sci (2007) 1.34
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol (2002) 1.32
Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl (2005) 1.30
Acute alcohol intoxication. Eur J Intern Med (2008) 1.29
Histopathology of the supraspinatus tendon in rotator cuff tears. Am J Sports Med (2007) 1.29
Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) (2010) 1.28
Para-articular osteochondroma of the knee. Arthroscopy (2006) 1.27
The stool antigen test for detection of Helicobacter pylori after eradication therapy. Ann Intern Med (2002) 1.25
Movin and Bonar scores assess the same characteristics of tendon histology. Clin Orthop Relat Res (2008) 1.24
Familial Mediterranean Fever: a review for clinical management. Joint Bone Spine (2008) 1.23
Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis (2007) 1.21
Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog (2013) 1.19
Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol (2005) 1.18
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol (2006) 1.17
Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology (2007) 1.17
CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis (2008) 1.15
Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol (2003) 1.15
Extragastric diseases and Helicobacter pylori. Helicobacter (2013) 1.14
Femoroacetabular impingement syndrome management: arthroscopy or open surgery? Int Orthop (2011) 1.13
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use. Cancer (2014) 1.13
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study. Eur J Cancer (2013) 1.12
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol (2009) 1.12
Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol (2007) 1.12
Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation (2002) 1.11
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget (2011) 1.11
Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol (2010) 1.11
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav (2005) 1.09
Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcohol Clin Exp Res (2006) 1.09
Faecal calprotectin concentrations in untreated coeliac patients. Scand J Gastroenterol (2007) 1.09
Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta (2012) 1.09
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem (2009) 1.09
How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiology (2005) 1.08
Sequential or combined treatment? That is the question. Radiology (2014) 1.07
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int J Antimicrob Agents (2009) 1.06
Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol (2008) 1.05
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol (2009) 1.05
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol (2012) 1.04